ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 632730 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 632730; 2) Community: the network communities that were significantly associated with the response to NSC 632730; 3) Molecule: the relationships between components within communities and NSC 632730; 4) MDR: the compounds that were significantly associated with the NSC 632730.

NSC Compound Enrichment Correlation
NSC 129794 Ethanesulfonic acid, compd. with 2-chloro-5-[4-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) 0.0105244982742819 -0.071567115
NSC 300289 Pinafide 0.0105244982742819 0.10525865
NSC 33570 Null 0.0105244982742819 0.12189799
NSC 339137 PHYSALOLACTONE 0.0105244982742819 0.028878235
NSC 339579 7H-Pyrrolo[3,2-f]quinazoline-2,4-diamine, 7-[(3-nitrophenyl)methyl]-, monoacetate 0.0105244982742819 0.20042375
NSC 351521 Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) 0.0105244982742819 0.13249336
NSC 606497 Camptothecin Derivative 0.0105244982742819 0.25265956
NSC 647763 Jasplakinolide epoxide C 0.0105244982742821 -0.31489666
NSC 674268 Null 0.0105244982742821 0.16876975
NSC 679006 2-Butenedioic acid, 2,2'-(5-methyl-2,4-dioxopyrimidine- 1,3-diyl)bis-, tetraethyl ester 0.0105244982742821 -0.023812169
Total:71  Current:14    [First] [Prev] [Next] [Last]